Hoboken-based John Wiley & Sons Inc., a global provider of professional learning and talent management, announced Thursday that it has acquired SimBioSys Inc., a provider of scientific software. Terms were not disclosed.
“Wiley has deep roots in top quality chemistry publishing with high-profile international chemistry society partnerships and extensive chemical databases, journals, books and references,” Steve Miron, senior vice president of Wiley’s Global Research business, said in a statement. “By combining our traditional published content and databases with machine learning algorithms, we can support chemists in innovative research as they advance world knowledge.”
"The acquisition of SimBioSys accelerates the development of Wiley Science Solutions, our integrated suite of workflow tools for researchers,” Dr. Mike Davis, vice president and managing director, Research Innovations, said in a statement. “SymBioSys has developed technology that enables the computer to learn organic chemistry. These tools enable chemists working in industry and academia to find new and better ways of synthesizing target compounds, saving them time and money.”
SymBioSys is headquartered in Toronto, Canada.
ALSO ON NJBIZ: